Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 12436337)

Published in Diabetologia on October 02, 2002

Authors

C Beysen1, F Karpe, B A Fielding, A Clark, J C Levy, K N Frayn

Author Affiliations

1: Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Infirmary, Oxford, UK.

Articles citing this

Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care (2012) 1.90

Effect of macronutrients and fiber on postprandial glycemic responses and meal glycemic index and glycemic load value determinations. Am J Clin Nutr (2017) 1.56

Monounsaturated fatty acids prevent the aversive effects of obesity on locomotion, brain activity, and sleep behavior. Diabetes (2012) 0.92

The effect on glucagon, glucagon-like peptide-1, total and acyl-ghrelin of dietary fats ingested with and without potato. J Clin Endocrinol Metab (2010) 0.86

Glu298Asp polymorphism influences the beneficial effects of fish oil fatty acids on postprandial vascular function. J Lipid Res (2012) 0.77

Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects. Eur J Nutr (2016) 0.77

The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. Adipocyte (2015) 0.76

Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal. BMC Endocr Disord (2016) 0.75

Glucagon-like peptide-1 and-2 levels in children with diabetic ketoacidosis. J Clin Res Pediatr Endocrinol (2009) 0.75

Letter: Regulating Hypothalamus Gene Expression in Food Intake: Dietary Composition or Calorie Density? (Diabetes Metab J 2017;41:121-7). Diabetes Metab J (2017) 0.75

Long chain saturated and unsaturated fatty acids exert opposing effects on viability and function of GLP-1-producing cells: Mechanisms of lipotoxicity. PLoS One (2017) 0.75

Response: Regulating Hypothalamus Gene Expression in Food Intake: Dietary Composition or Calorie Density? (Diabetes Metab J 2017;41:121-7). Diabetes Metab J (2017) 0.75

Appetite responses to high-fat meals or diets of varying fatty acid composition: a comprehensive review. Eur J Clin Nutr (2017) 0.75

Articles by these authors

Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care (1998) 8.29

Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol (1983) 6.45

Protective effect of breast feeding against infection. BMJ (1990) 5.88

Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19

Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) (2010) 3.86

A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet (2001) 3.26

Disease mapping models: an empirical evaluation. Disease Mapping Collaborative Group. Stat Med (2001) 2.88

Change in obstetric practice in response to fear of litigation in the British Isles. Lancet (1991) 2.78

Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1990) 2.65

Glycaemic index methodology. Nutr Res Rev (2005) 2.47

Relation between early introduction of solid food to infants and their weight and illnesses during the first two years of life. BMJ (1993) 2.46

Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation (2008) 2.38

Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2.34

Quality of life measurements in patients with malignant disease: a review. J R Soc Med (1986) 2.28

Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J (2002) 2.24

Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia (2010) 2.21

Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15

Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism (1996) 2.11

The use of various handwashing agents to decontaminate gloved hands. Br Dent J (1989) 2.03

Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia (2009) 2.03

The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy (2007) 1.91

Urinary albumin excretion in school children. Arch Dis Child (1984) 1.88

The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia (2009) 1.87

Regulation of protein metabolism by a physiological concentration of insulin in mouse soleus and extensor digitorum longus muscles. Effects of starvation and scald injury. Biochem J (1979) 1.84

The evidence for beta blockers in heart failure. BMJ (1999) 1.84

Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy (2011) 1.81

Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol (2001) 1.74

The heart failure epidemic: exactly how big is it? Eur Heart J (2001) 1.73

Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia (2002) 1.73

Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group. Pediatr Pulmonol (1998) 1.73

Analysis of pace-maker and repolarization currents in frog atrial muscle. J Physiol (1976) 1.72

Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol (1985) 1.68

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia (2004) 1.65

Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim Biophys Acta (2001) 1.63

Multivesicular exocytosis in rat pancreatic beta cells. Diabetologia (2011) 1.63

Oral androgens in the treatment of hypogonadal impotent men. J Urol (1994) 1.61

Adolescent depression, alcohol and drug abuse. Am J Public Health (1987) 1.61

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Stability of plasma glucose during storage. Ann Clin Biochem (1990) 1.59

Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study. Stroke (2003) 1.57

Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol (2001) 1.57

Immune-mediated reactions to althesin (alphaxalone). Br J Anaesth (1976) 1.56

Identification of the pace-maker current in frog atrium. J Physiol (1976) 1.56

Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia (2004) 1.54

Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci (2003) 1.53

A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)gammaa as a pancreatic beta cell-specific biomarker. Diabetologia (2010) 1.53

Do facial averageness and symmetry signal health? Evol Hum Behav (2001) 1.52

Functional health status levels of primary care patients. JAMA (1983) 1.52

Changes in blood flow close to subcutaneous insulin injection sites in stable and brittle diabetics. Diabetes (1983) 1.51

Age of appearance of circadian rhythm in salivary cortisol values in infancy. Arch Dis Child (1983) 1.49

Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines. J Biol Stand (1980) 1.48

The emergence of oseltamivir-resistant pandemic influenza A (H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill (2010) 1.46

Randomized clinical trial of fluid and salt restriction compared with a controlled liberal regimen in elective gastrointestinal surgery. Br J Surg (2013) 1.46

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions. J Biol Stand (1979) 1.45

'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance. Q J Med (1993) 1.43

Evaluation of Syva's enzyme immunoassay for the detection of Chlamydia trachomatis in urogenital specimens. Diagn Microbiol Infect Dis (1993) 1.42

Hormonal control of metabolism in trauma and sepsis. Clin Endocrinol (Oxf) (1986) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

A method for assessing quality of control from glucose profiles. Diabet Med (2007) 1.41

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res (1980) 1.40

Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care (2002) 1.39

Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J (Clin Res Ed) (1987) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Background turbidity changes during the estimation of urinary albumin. Ann Clin Biochem (1990) 1.38

Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia (2005) 1.38

Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia (2003) 1.37

Attractiveness of facial averageness and symmetry in non-western cultures: in search of biologically based standards of beauty. Perception (2001) 1.37

Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest. Q J Med (1985) 1.37

The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia (2005) 1.37

The relationships between plasma substrates and hormones and the severity of injury in 277 recently injured patients. Clin Sci (Lond) (1979) 1.36

Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia (1999) 1.36

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes (1999) 1.36

Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats. Biochem Pharmacol (1972) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation (1998) 1.34

Renal function in diabetes mellitus. Arch Dis Child (1985) 1.34

Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers. J Infect Dis (1978) 1.33

Molecular characterization of the alpha-glucosidase gene (malA) from the hyperthermophilic archaeon Sulfolobus solfataricus. J Bacteriol (1998) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci (Lond) (1990) 1.31

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

Spectrum of spontaneous frameshift mutations. Sequences of bacteriophage T4 rII gene frameshifts. J Mol Biol (1986) 1.28

Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27

Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci (1999) 1.27

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM. Diabetologia (1997) 1.27

Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ (1993) 1.27

Sample preparation with ion-exchange resin before liquid-chromatographic determination of plasma catecholamines. Clin Chem (1983) 1.26

Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet (2001) 1.26

Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism (1992) 1.26